Stay updated on Duvelisib for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Duvelisib for COVID-19 Clinical Trial page.

Latest updates to the Duvelisib for COVID-19 Clinical Trial page
- Check5 days agoChange DetectedAdded the revision label Revision: v3.4.3 to the page. Removed the previous revision label Revision: v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.4.0 was removed and v3.4.1 added, a minor software update with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdditions: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page's revision label updated from v3.3.3 to v3.3.4, with no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedA standalone Locations section now lists Missouri as a site, replacing the former Missouri Locations block; the HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Duvelisib for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib for COVID-19 Clinical Trial page.